Notice2022-19049
National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 2, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 170 (Friday, September 2, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 170 (Friday, September 2, 2022)]
[Notices]
[Pages 54225-54226]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-19049]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Research Education Program
Advancing the Careers of a Diverse Research Workforce (R25 Clinical
Trial Not Allowed).
Date: September 30, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G21,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific
Review Officer, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room
3G21, Rockville, MD 20892, 301-761-7176, <a href="/cdn-cgi/l/email-protection#74101d191d00061d1b075a021500151f1d07341a1d1c5a131b02"><span class="__cf_email__" data-cfemail="c7a3aeaaaeb3b5aea8b4e9b1a6b3a6acaeb487a9aeafe9a0a8b1">[email protected]</span></a>.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Biomarker Signatures of TB
Infection in Young Children With and Without HIV (R01 Clinical Trial
Not Allowed).
Date: October 4, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G21,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Dimitrios N. Vatakis, Ph.D., Scientific Review
Officer, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G21,
Rockville, MD 20892, 301-761-7176, <a href="/cdn-cgi/l/email-protection#91f5f8fcf8e5e3f8fee2bfe7f0e5f0faf8e2d1fff8f9bff6fee7"><span class="__cf_email__" data-cfemail="56323f3b3f22243f392578203722373d3f2516383f3e78313920">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
[[Page 54226]]
Dated: August 30, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19049 Filed 9-1-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 2, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.